Pediatric Crohn Disease Presenting as Appendicitis: Differentiating Features from Typical Appendicitis

Abstract

Background The initial presentation of Crohn disease (CD) may mimic acute appendicitis, and preoperative clues may aid in recognizing patients at risk for CD.

Methods A retrospective case control study of patients presenting over 10 years compared control patients with appendicitis versus patients presenting with appendicitis who ultimately developed CD. We matched 10 patients of the same age, gender, and perforated versus nonperforated appendicitis status for each of the CD patients. Demographic, laboratory, and clinical data were compared. Additionally, appendectomy specimens of CD patients were genotyped for common NOD2 (nucleotide-binding oligomerization domain-containing protein 2) mutations.

Results Of 2718 patients treated for appendicitis, 8 subsequently developed CD. Compared to the matched controls, CD patients were found to have lower hemoglobin (10.4 + 1.0 vs. 13.3 + 0.2, p < 0.0001) and mean corpuscular volume (MCV) (72.5 + 3.4 vs. 84.1 + 0.5, p < 0.0001) values, and higher platelets values (444.8 + 42.2 vs. 275.6 + 8.0, p < 0.0001) at initial presentation. Anthropometric z-scores, length of stay, and antibiotic therapy duration did not significantly differ between groups. The NOD2 mutation frequency (25%) was consistent with the currently described CD population.

Conclusions Preoperative findings of a low hemoglobin level and MCV count, and a high platelet count in a child presenting with appendicitis warrant further evaluation for CD, as prompt diagnosis allows for optimal treatment and quality of life for these patients.

Keywords

appendicitis - Crohn disease - NOD2 mutations

• References

• 1 Andersson RE, Olaison G, Tysk C, Ekbom A. Appendectomy is followed by increased risk of Crohn's disease. Gastroenterology 2003; 124 (1) 40-46
• 2 Koutroubakis IE, Vlachonikolis IG, Kouroumalis EA. Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: a critical review. Inflamm Bowel Dis 2002; 8 (4) 277-286
• 3 Koutroubakis IE, Vlachonikolis IG. Appendectomy and the development of ulcerative colitis: results of a metaanalysis of published case-control studies. Am J Gastroenterol 2000; 95 (1) 171-176
• 4 Kaplan GG, Jackson T, Sands BE, Frisch M, Andersson RE, Korzenik J. The risk of developing Crohn's disease after an appendectomy: a meta-analysis. Am J Gastroenterol 2008; 103 (11) 2925-2931
• 5 Kurina LM, Goldacre MJ, Yeates D, Seagroatt V. Appendicectomy, tonsillectomy, and inflammatory bowel disease: a case-control record linkage study. J Epidemiol Community Health 2002; 56 (7) 551-554
• 6 Frisch M, Johansen C, Mellemkjaer L , et al. Appendectomy and subsequent risk of inflammatory bowel diseases. Surgery 2001; 130 (1) 36-43
• 7 Kaplan GG, Pedersen BV, Andersson RE, Sands BE, Korzenik J, Frisch M. The risk of developing Crohn's disease after an appendectomy: a population-based cohort study in Sweden and Denmark. Gut 2007; 56 (10) 1387-1392
• 8 Russel MG, Dorant E, Brummer RJ , et al; South Limburg Inflammatory Bowel Disease Study Group. Appendectomy and the risk of developing ulcerative colitis or Crohn's disease: results of a large case-control study. Gastroenterology 1997; 113 (2) 377-382
• 9 Oren R, Rachmilewitz D. Preoperative clues to Crohn's disease in suspected, acute appendicitis. Report of 12 cases and review of the literature. J ClinGastroenterol 1992; 15 (4) 306-310
• 10 Lichtenstein GR. Emerging prognostic markers to determine Crohn's disease natural history and improve management strategies: a review of recent literature. GastroenterolHepatol (N Y) 2010; 6 (2) 99-107
• 11 Lesage S, Zouali H, Cézard JP , et al; EPWG-IBD Group; EPIMAD Group; GETAID Group. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002; 70 (4) 845-857
• 12 Cuthbert AP, Fisher SA, Mirza MM , et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002; 122 (4) 867-874
• 13 Weiss B, Shamir R, Bujanover Y , et al. NOD2/CARD15 mutation analysis and genotype-phenotype correlation in Jewish pediatric patients compared with adults with Crohn's disease. J Pediatr 2004; 145 (2) 208-212
• 14 Vermeire S, Wild G, Kocher K , et al. CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet 2002; 71 (1) 74-83
• 15 Hugot JP, Zaccaria I, Cavanaugh J , et al; for the IBD International Genetics Consortium. Prevalence of CARD15/NOD2 mutations in Caucasian healthy people. Am J Gastroenterol 2007; 102 (6) 1259-1267
• 16 Esters N, Pierik M, van Steen K , et al. Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease. Am J Gastroenterol 2004; 99 (2) 299-305
• 17 Radlmayr M, Török HP, Martin K, Folwaczny C. The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology 2002; 122 (7) 2091-2092
• 18 Ogura Y, Bonen DK, Inohara N , et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411 (6837) 603-606